Your browser doesn't support javascript.
loading
Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma.
Ju, Wei; Zhang, Meili; Wilson, Kelli M; Petrus, Michael N; Bamford, Richard N; Zhang, Xiaohu; Guha, Rajarshi; Ferrer, Marc; Thomas, Craig J; Waldmann, Thomas A.
Afiliação
  • Ju W; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
  • Zhang M; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Laboratory Animal Science Program, Leidos Biomedical Research, Inc., Frederick, MD 21702;
  • Wilson KM; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850;
  • Petrus MN; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
  • Bamford RN; Transponics, Jacobus, PA 17407.
  • Zhang X; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850;
  • Guha R; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850;
  • Ferrer M; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850;
  • Thomas CJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850;
  • Waldmann TA; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; tawald@helix.nih.gov.
Proc Natl Acad Sci U S A ; 113(6): 1624-9, 2016 Feb 09.
Article em En | MEDLINE | ID: mdl-26811457

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Sulfonamidas / Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Imunoconjugados / Compostos de Anilina Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Sulfonamidas / Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Imunoconjugados / Compostos de Anilina Idioma: En Ano de publicação: 2016 Tipo de documento: Article